The use of surfactant in children with acute respiratory distress syndrome: efficacy in terms of oxygenation, ventilation and mortality.

H. Yapıcıoğlu,D. Yıldızdaş,I. Bayram,Y. Sertdemir,H. Yilmaz

DOI: https://doi.org/10.1016/S1094-5539(03)00088-9

IF: 3.282

2003-12-01

Pulmonary Pharmacology & Therapeutics

Abstract:

What problem does this paper attempt to address?

Novel POU3F4 variants identified in patients with inner ear malformations exhibit aberrant cellular distribution and lack of SLC6A20 transcriptional upregulation

Emanuele Bernardinelli,Sebastian Roesch,Edi Simoni,Angela Marino,Gerd Rasp,Laura Astolfi,Antonio Sarikas,Silvia Dossena

DOI: https://doi.org/10.3389/fnmol.2022.999833

2022-09-30

Frontiers in Molecular Neuroscience

Abstract:Hearing loss (HL) is the most common sensory defect and affects 450 million people worldwide in a disabling form. Pathogenic sequence alterations in the POU3F4 gene, which encodes a transcription factor, are causative of the most common type of X-linked deafness (X-linked deafness type 3, DFN3, DFNX2). POU3F4-related deafness is characterized by a typical inner ear malformation, namely an incomplete partition of the cochlea type 3 (IP3), with or without an enlargement of the vestibular aqueduct (EVA). The pathomechanism underlying POU3F4-related deafness and the corresponding transcriptional targets are largely uncharacterized. Two male patients belonging to a Caucasian cohort with HL and EVA who presented with an IP3 were submitted to genetic analysis. Two novel sequence variants in POU3F4 were identified by Sanger sequencing. In cell-based assays, the corresponding protein variants (p.S74Afs*8 and p.C327*) showed an aberrant expression and subcellular distribution and lack of transcriptional activity. These two protein variants failed to upregulate the transcript levels of the amino acid transporter gene SLC6A20 , which was identified as a novel transcriptional target of POU3F4 by RNA sequencing and RT-qPCR. Accordingly, POU3F4 silencing by siRNA resulted in downregulation of SLC6A20 in mouse embryonic fibroblasts. Moreover, we showed for the first time that SLC6A20 is expressed in the mouse cochlea, and co-localized with POU3F4 in the spiral ligament. The findings presented here point to a novel role of amino acid transporters in the inner ear and pave the way for mechanistic studies of POU3F4-related HL.

neurosciences
Application of a hybrid grounding scheme to a paper mill 13.8 kV generator

D. Moody,V. Beachum,T. Natali,W. Vilcheck,D. Shipp

DOI: https://doi.org/10.1109/PAPCON.2003.1216906

2003-06-16

Abstract:Many paper mills and other industries use turbine generators to supply critical process steam and electrical generation needs within the plant. The loss of a generating unit for an extended period would result in very costly replacement power and repair costs for any paper mill. As machine insulation systems age over decades, aging mechanisms progress to increase the risk of a possible ground fault internal to the generator. An IEEE/IAS Working Group Report submitted in 2002 discusses grounding and ground fault protection for medium voltage generator stators, highlighting their merits and drawbacks. The report is intended as a guide for engineers installing new or upgrading existing generator systems to minimize industrial bus connected generator damage from stator ground faults. This paper discusses a 13.8 kV generator upgrade at a paper mill employing the hybrid grounding scheme and ground fault protection evaluated favorably by the IEEE/IAS Working Group. Project tasks are described in detail. Issues and difficulties encountered during the course of the generator grounding upgrade which were not mentioned in the Working Group Report are presented for reference.
Clinical and Molecular Aspects Associated with Defects in the Transcription Factor POU3F4: A Review

Emanuele Bernardinelli,Florian Huber,Sebastian Roesch,Silvia Dossena

DOI: https://doi.org/10.3390/biomedicines11061695

IF: 4.757

2023-06-13

Biomedicines

Abstract:X-linked deafness (DFNX) is estimated to account for up to 2% of cases of hereditary hearing loss and occurs in both syndromic and non-syndromic forms. POU3F4 is the gene most commonly associated with X-linked deafness (DFNX2, DFN3) and accounts for about 50% of the cases of X-linked non-syndromic hearing loss. This gene codes for a transcription factor of the POU family that plays a major role in the development of the middle and inner ear. The clinical features of POU3F4-related hearing loss include a pathognomonic malformation of the inner ear defined as incomplete partition of the cochlea type 3 (IP-III). Often, a perilymphatic gusher is observed upon stapedectomy during surgery, possibly as a consequence of an incomplete separation of the cochlea from the internal auditory canal. Here we present an overview of the pathogenic gene variants of POU3F4 reported in the literature and discuss the associated clinical features, including hearing loss combined with additional phenotypes such as cognitive and motor developmental delays. Research on the transcriptional targets of POU3F4 in the ear and brain is in its early stages and is expected to greatly advance our understanding of the pathophysiology of POU3F4-linked hearing loss.

biochemistry & molecular biology,medicine, research & experimental,pharmacology & pharmacy
Novel and De Novo Mutations Extend Association of POU3F4 with Distinct Clinical and Radiological Phenotype of Hearing Loss

Agnieszka Pollak,Urszula Lechowicz,Anna Kędra,Piotr Stawiński,Małgorzata Rydzanicz,Mariusz Furmanek,Małgorzata Brzozowska,Maciej Mrówka,Henryk Skarżyński,Piotr H. Skarżyński,Monika Ołdak,Rafał Płoski

DOI: https://doi.org/10.1371/journal.pone.0166618

IF: 3.7

2016-12-12

PLoS ONE

Abstract:POU3F4 mutations (DFNX2) are the most prevalent among non-syndromic X-linked hearing loss (HL) identified to date. Clinical manifestations of DFNX2 usually comprise congenital HL either sensorineural or mixed, a tendency towards perilymphatic gusher during otologic surgery and temporal bone malformations. The aim of the present study was to screen for POU3F4 mutations in a group of 30 subjects with a suggestive clinical phenotype as well as a group (N = 1671-2018) of unselected hearing loss patients. We also planned to analyze audiological and radiological features in patients with HL caused by POU3F4 defects. The molecular techniques used to detect POU3F4 mutations included whole exome sequencing (WES), Sanger sequencing and real-time polymerase chain reaction. Hearing status was assessed with pure-tone audiometry and auditory brainstem response. Computer tomography scans were evaluated to define the pattern of structural changes in the temporal bones. Six novel (p.Gln27*, p.Glu187*, p.Leu217*, p.Gln275*, p.Gln306*, p.Val324Asp) and two known (p.Ala116fs141*, p.Leu208*) POU3F4 mutations were detected in the studied cohort. All probands with POU3F4 defects suffered from bilateral, prelingual, severe to profound HL. Morphological changes of the temporal bone in these patients presented a similar pattern, including malformations of the internal auditory canal, vestibular aqueduct, modiolus and vestibule. Despite different localization in the POU3F4 gene all mutations severely impair the protein structure affecting at least one functional POU3F4 domain, and results in similar and severe clinical manifestations. Sequencing of the entire POU3F4 gene is recommended in patients with characteristic temporal bone malformations. Results of POU3F4 mutation testing are important not only for a proper genetic counseling, but also for adequate preparation and conduction of a surgical procedure.

multidisciplinary sciences
A Parallel Sparse Linear Solver for Nearest-Neighbor Tight-Binding Problems

M. Luisier,Gerhard Klimeck,A. Schenk,W. Fichtner,T. Boykin

DOI: https://doi.org/10.1007/978-3-540-85451-7_84

2008-08-26

Abstract:
A POU3F4 Mutation Causes Nonsyndromic Hearing Loss in a Chinese X-linked Recessive Family

Wan Du,Ming-Kun Han,Da-Yong Wang,Bing Han,Liang Zong,Lan Lan,Ju Yang,Qi Shen,Lin-Yi Xie,Lan Yu,Jing Guan,Qiu-Ju Wang

DOI: https://doi.org/10.4103/0366-6999.196565

IF: 6.133

2017-01-05

Chinese Medical Journal

Abstract:BACKGROUND: The molecular genetic research showed the association between X-linked hearing loss and mutations in POU3F4. This research aimed to identify a POU3F4 mutation in a nonsyndromic X-linked recessive hearing loss family.METHODS: A series of clinical evaluations including medical history, otologic examinations, family history, audiologic testing, and a high-resolution computed tomography scan were performed for each patient. Bidirectional sequencing was carried out for all polymerase chain reaction products of the samples. Moreover, 834 controls with normal hearing were also tested.RESULTS: The pedigree showed X-linkage recessive inheritance pattern, and pathogenic mutation (c.499C>T) was identified in the proband and his family member, which led to a premature termination prior to the entire POU domains. This mutation co-segregated with hearing loss in this family. No mutation of POU3F4 gene was found in 834 controls.CONCLUSIONS: A nonsense mutation is identified in a family displaying the pedigree consistent with X-linked recessive pattern in POU3F4 gene. In addition, we may provide molecular diagnosis and genetic counseling for this family.

medicine, general & internal
Clinical and molecular characterization of POU3F4 mutations in multiple DFNX2 Chinese families

Yu Su,Xue Gao,Sha-Sha Huang,Jing-Ning Mao,Bang-Qing Huang,Jian-Dong Zhao,Dong-Yang Kang,Xin Zhang,Pu Dai

DOI: https://doi.org/10.1186/s12881-018-0630-9

2018-09-04

BMC Medical Genetics

Abstract:BackgroundMany X-linked non-syndromic hearing loss (HL) cases are caused by various mutations in the POU domain class 3 transcription factor 4 (POU3F4) gene. This study aimed to identify allelic variants of this gene in two Chinese families displaying X-linked inheritance deafness-2 (DFNX2) and one sporadic case with indefinite inheritance pattern.MethodsDirect DNA sequencing of the POU3F4 gene was performed in these families and in 100 Chinese individuals with normal hearing.ResultsThere are characteristic imaging findings in DFNX2 Chinese families with POU3F4 mutations. The temporal bone computed tomography (CT) images of patients with DFNX2 are characterized by a thickened stapes footplate, hypoplasia of the cochlear base, absence of the bony modiolus, and dilated internal acoustic meatus (IAM) as well as by abnormally wide communication between the IAM and the basal turn of the cochlea. We identified three causative mutations in POU3F4 for three probands and their extended families. In family 1468, we observed a novel deletion mutation, c.973delT, which is predicted to result in a p.Trp325Gly amino acid frameshift. In family 2741, the mutation c.927delCTC was identified, which is predicted to result in the deletion of serine at position 310. In both families, the mutations were located in the POU homeodomain and are predicted to truncate the C-terminus of the POU domain. In the third family, a novel de novo transversion mutation (c.669 T > A) was identified in a 5-year-old boy that resulted in a nonsense mutation (p.Tyr223*). The mutation created a new stop codon and is predicted to result in a truncated POU3F4 protein.ConclusionsBased on characteristic radiological findings and clinical features, POU3F4 gene mutation analysis will increase the success rate of stapes operations and cochlear implantations, and improve molecular diagnosis, genetic counseling, and knowledge of the molecular epidemiology of HL among patients with DFNX2.

genetics & heredity
ANTIBIOTIC-INDUCED ENDOTOXIN RELEASE

J. Cohen,J. S. Mcconnell

DOI: https://doi.org/10.1016/S0140-6736(85)90939-0

IF: 202.731

1985-11-09

The Lancet

Abstract:
De Novo Mutation in X-Linked Hearing Loss–Associated POU3F4 in a Sporadic Case of Congenital Hearing Loss

Hideaki Moteki,A. Eliot Shearer,Shuji Izumi,Yamato Kubota,Hela Azaiez,Kevin T. Booth,Christina M. Sloan,Diana L. Kolbe,Richard J. H. Smith,Shin-ichi Usami

DOI: https://doi.org/10.1177/0003489415575042

2015-03-19

Abstract:Objectives: In this report, we present a male patient with no family history of hearing loss, in whom we identified a novel de novo mutation in the POU3F4 gene. Methods: One hundred ninety-four (194) Japanese subjects from unrelated and nonconsanguineous families were enrolled in this study. We used targeted genomic enrichment and massively parallel sequencing of all known nonsyndromic hearing loss genes for identifying the genetic causes of hearing loss. Results: A novel de novo frameshift mutation of POU3F4 to c.727_728insA (p.N244KfsX26) was identified. The patient was a 7-year-old male with congenital progressive hearing loss and inner ear deformity. Although the patient had received a cochlear implant, auditory skills were still limited. The patient also exhibited developmental delays similar to those previously associated with POU3F4 mutation. Conclusion: This is the first report of a mutation in POU3F4 causing hearing loss in a Japanese patient without a family history of hearing loss. This study underscores the importance of comprehensive genetic testing of patients with hearing loss for providing accurate prognostic information and guiding the optimal management of patient rehabilitation.
Molecular Analysis of the Pou3F4 Gene in Patients with Clinical and Radiographic Evidence of X-Linked Mixed Deafness with Perilymphatic Gusher

Yelena Bykhovskaya,David F. Wilson,Rick A. Friedman,George Tu,Lorne S. Farnes,J. Michael Talbot,Nathan Fischel-Ghodsian

DOI: https://doi.org/10.1177/000348949710600411

1997-04-01

Abstract:The molecular defect in some patients with X-linked mixed deafness with perilymphatic gusher at stapes surgery (DEN3) was recently attributed to mutations in the POU3F4 gene. In this manuscript we describe the molecular analysis of the POU3F4 gene in 5 patients with clinical and radiographic evidence of DFN3. Novel mutations were found in 2 of the 5 patients analyzed, while 3 had an entirely normal protein coding sequence. The fact that 3 of the 5 patients with clinical histories and radiographic abnormalities characteristic of X-linked mixed deafness with perilymphatic gusher displayed normal POU3F4 gene sequences supports the possibility that not all patients with the characteristic phenotype have involvement of the POU3F4 gene.
The pediatric clerkship director. Support systems, professional development, and academic credentials.

L. Greenberg,O. J. Sahler,B. Siegel,R. Sarkin,S. Sharkey

DOI: https://doi.org/10.1001/ARCHPEDI.1995.02170210090016

1995-08-01

Abstract:Since the advent of the clerkship at The Johns Hopkins Medical School in the late 19th century, this model has been the backbone of clinical training for medical students throughout the world. Despite the pervasiveness of clerkships, little information exists about the faculty that oversees them administratively. We documented the reported academic credentials, professional development, and support systems for pediatric clerkship directors in the United States and Canada. Our findings should be useful to clerkship directors and department chairpersons across disciplines.
Phenotype and genotype in females with POU3F4 mutations

S Marlin,M P Moizard,A David,N Chaissang,M Raynaud,L Jonard,D Feldmann,N Loundon,F Denoyelle,A Toutain

DOI: https://doi.org/10.1111/j.1399-0004.2009.01215.x

Abstract:X-linked deafness is a rare cause of hereditary isolated hearing impairment estimated as at least 1% or 2% of the non-syndromic hearing loss. To date, four loci for DFN have been identified and only one gene, POU3F4 responsible for DFN3, has been cloned. In males, DFN3 is characterized by a progressive deafness associated with perilymphatic gusher at stapes surgery and with a characteristic inner ear malformation. The phenotype of eight independent females carrying POU3F4 anomalies is defined, and a late-onset hearing loss is found in three patients. Only one has an inner ear malformation. No genotype/phenotype correlation is identified.
Pou3f4 deficiency causes defects in otic fibrocytes and stria vascularis by different mechanisms

Mee Hyun Song,Soo-Young Choi,Ling Wu,Se-Kyoung Oh,Hee Keun Lee,Dong Jin Lee,Dae-Bo Shim,Jae Young Choi,Un-Kyung Kim,Jinwoong Bok

DOI: https://doi.org/10.1016/j.bbrc.2010.12.019

2011-01-07

Abstract:DFN3, the most prevalent X-linked hearing loss, is caused by mutations in the POU3F4 gene. Previous studies in Pou3f4 knockout mice suggest that defective otic fibrocytes in the spiral ligament of the cochlear lateral wall may underlie the hearing loss in DFN3. To better understand the pathological mechanisms of the DFN3 hearing loss, we analyzed inner ears of Pou3f4-deficient mice during development. Our results indicate that compartmentalization of the spiral ligament mesenchyme setting up boundaries for specific otic fibrocytes occurs normally in Pou3f4-deficient cochlea. However, differentiation of the compartmentalized mesenchyme into specific otic fibrocytes was blocked in the absence of Pou3f4 function. In addition, we found that stria vascularis in the cochlear lateral wall was also affected in Pou3f4-deficient cochlea. Unlike the otic fibrocytes, differentiation of stria vascularis was completed in the absence of Pou3f4 function, yet expression of Kir4.1 channels in the strial intermediate cells, essential for the sound transduction, was lost afterwards. These results suggest that Pou3f4 deficiency causes defects in both otic fibrocytes and stria vascularis at different developmental stages and by different pathological mechanisms, which may account for the progressive nature of DFN3 hearing loss.
The transcription factor Pou4f3 is essential for the survival of postnatal and adult mouse cochlear hair cells and normal hearing

Jarnail Singh,Michelle R. Randle,Bradley J. Walters,Brandon C. Cox

DOI: https://doi.org/10.3389/fncel.2024.1369282

2024-03-19

Frontiers in Cellular Neuroscience

Abstract:Introduction: Hair cells (HCs) of the cochlea are responsible for sound transduction and hearing perception in mammals. Genetic mutations in the transcription factor Pou4f3 cause non-syndromic autosomal dominant hearing loss in humans (DFNA15) which varies in the age of onset depending on the individual mutation. Mouse models with germline deletion or mutations in Pou4f3 have previously demonstrated its critical role in the maturation and survival of cochlear HCs during embryonic development. However, the role of Pou4f3 in auditory function and in the survival or maintenance of cochlear HCs after birth and during adulthood has not been studied. Methods: Therefore, using the inducible CreER-loxP system, we deleted Pou4f3 from mouse cochlear HCs at different postnatal ages, relevant to specific stages of HC maturation and hearing function. Results and discussion: Elevated auditory brainstem response thresholds and significant HC loss were detected in mice with Pou4f3 deletion compared to their control littermates, regardless of the age when Pou4f3 was deleted. However, HC loss occurred more rapidly when Pou4f3 was deleted from immature HCs. Additionally, HC loss caused by Pou4f3 deletion did not affect the number of cochlear supporting cells, but caused a delayed loss of spiral ganglion neurons at 4 months after the deletion. In conclusion, Pou4f3 is necessary for the survival of cochlear HCs and normal hearing at all postnatal ages regardless of their maturation state. Our data also suggest that Pou4f3 indirectly regulates the survival of spiral ganglion neurons.

neurosciences
Phosphatidylinositol 4-kinase β mutations cause nonsyndromic sensorineural deafness and inner ear malformation

Xiulan Su,Yufei Feng,Sofia A Rahman,Shuilong Wu,Guoan Li,Franz Rüschendorf,Lei Zhao,Hongwei Cui,Junqing Liang,Liang Fang,Hao Hu,Sebastian Froehler,Yong Yu,Giannino Patone,Oliver Hummel,Qinghua Chen,Klemens Raile,Friedrich C Luft,Sylvia Bähring,Khalid Hussain,Wei Chen,Jingjing Zhang,Maolian Gong,Sofia A. Rahman,Friedrich C. Luft

DOI: https://doi.org/10.1016/j.jgg.2020.07.008

IF: 5.723

2020-10-01

Journal of Genetics and Genomics

Abstract:Congenital hearing loss is a common disorder worldwide. Heterogeneous gene variation accounts for approximately 20% - 25% of such patients. We investigated a five-generation Chinese family with autosomal-dominant non-syndromic sensorineural hearing loss (SNHL). No wave was detected in the pure-tone audiometry and auditory brainstem response (ABR) was absent in all patients. Computerized tomography (CT) in the patients, as well as in two sporadic SNHL cases showed bilateral inner ear anomaly, cochlear mal-development, absence of the osseous spiral lamina, and enlarged vestibular aqueduct. Such findings were absent in nonaffected persons. We used linkage analysis and exome sequencing and uncovered a heterozygous missense mutation in the PI4KB gene (p.Gln121Arg) encoding phosphatidylinositol 4 kinase-β (PI4KB) from the patients in this family. Additionally, 3 missense PI4KB (p.Val434Gly, p.Glu667Lys, and p.Met739Arg) mutations were identified in five non-syndromic SNHL patients from 57 sporadic cases No such mutations were present within 600 Chinese controls, the 1000 genome project, gnomAD, or similar databases. Depleting pi4kb mRNA expression in zebrafish caused inner ear abnormalities and audio-sensory impairment, mimicking the patient phenotypes. Moreover, over-expression of 4 human missense PI4KB mutant mRNAs in zebrafish embryos resulted in impaired hearing function, suggesting dominant-negative effects. Taken together, our results reveal that PI4KB mutations can cause SNHL and inner ear malformation. PI4KB should be included in neonatal deafness screening.

genetics & heredity,biochemistry & molecular biology
Identification of a Novel Frameshift Variant of POU3F4 and Genetic Counseling of Korean Incomplete Partition Type III Subjects Based on Detailed Genotypes

Jeong Hun Jang,Jayoung Oh,Jin Hee Han,Hye-Rim Park,Bong Jik Kim,Sejoon Lee,Min Young Kim,Seungmin Lee,Doo-Yi Oh,Yun-Hoon Choung,Byung Yoon Choi

DOI: https://doi.org/10.1089/gtmb.2018.0296

Abstract:Aim: The aim of this study was to report a novel POU Class 3 Homeobox 4 (POU3F4) variant and to provide further guidance on genetic counseling for incomplete partition (IP) type III families in the Korean population by showing two new contrasting cases in terms of genotypes and inheritance. Materials and Methods: Two consecutively recruited hearing-impaired probands with seemingly nonsyndromic features and their biological mothers were included in this study. Sanger sequencing and quantitative polymerase chain reaction (PCR) assays were performed for POU3F4. Results: A novel frameshift variant of POU3F4, c.852delC (p.Ile285Serfs*3), was identified in one of the patients. This mutation is predicted to truncate the protein within the POU homeodomain, resulting in the complete loss of the last nucleus localization signal. The proband's biological mother was also shown to be a carrier of this c.852delC (p.Ile285Serfs*3) mutant allele. A de novo genomic deletion on chromosome Xq21.2 was confirmed in another subject via quantitative PCR. This subject's biological mother, however, was not a carrier of this deletion. This indicates that the large upstream deletion of POU3F4 in the second proband occurred de novo. This finding is compatible with the previously proposed tendency for a high de novo rate of large genomic deletions involving the X-linked deafness-2 (DFNX2) locus. Conclusion: This study adds a novel, probably pathogenic POU3F4 truncation variant to the literature and provides guidance toward effective genetic counseling for IP III subjects based on more frequent de novo occurrence of POU3F4 deletions than POU3F4 point variants.
Characterization of new otic enhancers of the pou3f4 gene reveal distinct signaling pathway regulation and spatio-temporal patterns

Àlex Robert-Moreno,Silvia Naranjo,Elisa de la Calle-Mustienes,José Luis Gómez-Skarmeta,Berta Alsina

DOI: https://doi.org/10.1371/journal.pone.0015907

IF: 3.7

2010-12-31

PLoS ONE

Abstract:POU3F4 is a member of the POU-homedomain transcription factor family with a prominent role in inner ear development. Mutations in the human POU3F4 coding unit leads to X-linked deafness type 3 (DFN3), characterized by conductive hearing loss and progressive sensorineural deafness. Microdeletions found 1 Mb 5' upstream of the coding region also displayed the same phenotype, suggesting that cis-regulatory elements might be present in that region. Indeed, we and others have recently identified several enhancers at the 1 Mb 5' upstream interval of the pou3f4 locus. Here we characterize the spatio-temporal patterns of these regulatory elements in zebrafish transgenic lines. We show that the most distal enhancer (HCNR 81675) is activated earlier and drives GFP reporter expression initially to a broad ear domain to progressively restrict to the sensory patches. The proximal enhancer (HCNR 82478) is switched later during development and promotes expression, among in other tissues, in sensory patches from its onset. The third enhancer (HCNR 81728) is also active at later stages in the otic mesenchyme and in the otic epithelium. We also characterize the signaling pathways regulating these enhancers. While HCNR 81675 is regulated by very early signals of retinoic acid, HCNR 82478 is regulated by Fgf activity at a later stage and the HCNR 81728 enhancer is under the control of Hh signaling. Finally, we show that Sox2 and Pax2 transcription factors are bound to HCNR 81675 genomic region during otic development and specific mutations to these transcription factor binding sites abrogates HCNR 81675 enhancer activity. Altogether, our results suggest that pou3f4 expression in inner ear might be under the control of distinct regulatory elements that fine-tune the spatio-temporal activity of this gene and provides novel data on the signaling mechanisms controlling pou3f4 function.
Knock-In Mice with Myo3a Y137C Mutation Displayed Progressive Hearing Loss and Hair Cell Degeneration in the Inner Ear

Peipei Li,Zongzhuang Wen,Guangkai Zhang,Aizhen Zhang,Xiaolong Fu,Jiangang Gao

DOI: https://doi.org/10.1155/2018/4372913

2018-07-05

Abstract:Myo3a is expressed in cochlear hair cells and retinal cells and is responsible for human recessive hereditary nonsyndromic deafness (DFNB30). To investigate the mechanism of DFNB30-type deafness, we established a mouse model of Myo3a kinase domain Y137C mutation by using CRISPR/Cas9 system. No difference in hearing between 2-month-old Myo3a mutant mice and wild-type mice was observed. The hearing threshold of the ≥6-month-old mutant mice was significantly elevated compared with that of the wild-type mice. We observed degeneration in the inner ear hair cells of 6-month-old Myo3a mutant mice, and the degeneration became more severe at the age of 12 months. We also found structural abnormality in the cochlear hair cell stereocilia. Our results showed that Myo3a is essential for normal hearing by maintaining the intact structure of hair cell stereocilia, and the kinase domain plays a critical role in the normal functions of Myo3a. This mouse line is an excellent model for studying DFNB30-type deafness in humans.
Genetic findings of Sanger and nanopore single-molecule sequencing in patients with X-linked hearing loss and incomplete partition type III

Ying Chen,Jiajun Qiu,Yingwei Wu,Huan Jia,Yi Jiang,Mengda Jiang,Zhili Wang,Hai-Bin Sheng,Lingxiang Hu,Zhihua Zhang,Zhaoyan Wang,Yun Li,Zhiwu Huang,Hao Wu

DOI: https://doi.org/10.1186/s13023-022-02235-7

2022-02-21

Abstract:Background: POU3F4 is the causative gene for X-linked deafness-2 (DFNX2), characterized by incomplete partition type III (IP-III) malformation of the inner ear. The purpose of this study was to investigate the clinical characteristics and molecular findings in IP-III patients by Sanger or nanopore single-molecule sequencing. Methods: Diagnosis of IP-III was mainly based on clinical characteristics including radiological and audiological findings. Sanger sequencing of POU3F4 was carried out for these IP-III patients. For those patients with negative results for POU3F4 Sanger sequencing, nanopore long-read single-molecule sequencing was used to identify the possible pathogenic variants. Hearing intervention outcomes of hearing aids (HAs) fitting and cochlear implantation (CI) were also analyzed. Aided pure tone average (PTA) was further compared between two groups of patients according to their different locations of POU3F4 variants: in the exon region or in the upstream region. Results: In total, 18 male patients from 14 unrelated families were diagnosed with IP-III. 10 variants were identified in POU3F4 by Sanger sequencing and 6 of these were reported for the first time (p.Gln181*, p.Val215Gly, p.Arg282Gln, p.Gln316*, c.903_912 delins TGCCA and p.Arg205del). Four different deletions that varied from 80 to 486 kb were identified 876-1503 kb upstream of POU3F4 by nanopore long-read single-molecule sequencing. De novo genetic mutations occurred in 21.4% (3/14) of patients with POU3F4 mutations. Among these 18 patients, 7 had bilateral HAs and 10 patients received unilateral CI. The mean aided PTA for HAs and CI users were 41.1 ± 5.18 and 40.3 ± 7.59 dB HL respectively. The mean PTAs for patients with the variants located in the exon and upstream regions were 39.6 ± 6.31 versus 43.0 ± 7.10 dB HL, which presented no significant difference (p = 0.342). Conclusions: Among 14 unrelated IP-III patients, 28.6% (4/14) had no definite mutation in exon region of POU3F4. However, possible pathogenic deletions were identified in upstream region of this gene. De novo genetic mutations occurred in 21.4% (3/14) of patients with POU3F4 mutation. There was no significant difference of hearing intervention outcomes between the IP-III patients with variants located in the exon region and in the upstream region.
Intraepidermal nerve fibre density at wrist level in diabetic and non‐diabetic patients

Niels O.B. Thomsen,Elisabet Englund,S. Thrainsdottir,Ingmar Rosén,Lars B. Dahlin

DOI: https://doi.org/10.1111/j.1464-5491.2009.02823.x

IF: 3.5

2009-11-01

Diabetic Medicine

Abstract:Aims Myelinated nerve fibre pathology has been demonstrated at wrist level in diabetic patients. We examined if quantification of intra‐epidermal nerve fibre density (IENFD) in hairy and glabrous skin at wrist level could detect signs of subclinical small nerve fibre neuropathy.

The use of surfactant in children with acute respiratory distress syndrome: efficacy in terms of oxygenation, ventilation and mortality.

Novel POU3F4 variants identified in patients with inner ear malformations exhibit aberrant cellular distribution and lack of SLC6A20 transcriptional upregulation

Application of a hybrid grounding scheme to a paper mill 13.8 kV generator

Clinical and Molecular Aspects Associated with Defects in the Transcription Factor POU3F4: A Review

Novel and De Novo Mutations Extend Association of POU3F4 with Distinct Clinical and Radiological Phenotype of Hearing Loss

A Parallel Sparse Linear Solver for Nearest-Neighbor Tight-Binding Problems

A POU3F4 Mutation Causes Nonsyndromic Hearing Loss in a Chinese X-linked Recessive Family

Clinical and molecular characterization of POU3F4 mutations in multiple DFNX2 Chinese families

ANTIBIOTIC-INDUCED ENDOTOXIN RELEASE

De Novo Mutation in X-Linked Hearing Loss–Associated POU3F4 in a Sporadic Case of Congenital Hearing Loss

Molecular Analysis of the Pou3F4 Gene in Patients with Clinical and Radiographic Evidence of X-Linked Mixed Deafness with Perilymphatic Gusher

The pediatric clerkship director. Support systems, professional development, and academic credentials.

Phenotype and genotype in females with POU3F4 mutations

Pou3f4 deficiency causes defects in otic fibrocytes and stria vascularis by different mechanisms

The transcription factor Pou4f3 is essential for the survival of postnatal and adult mouse cochlear hair cells and normal hearing

Phosphatidylinositol 4-kinase β mutations cause nonsyndromic sensorineural deafness and inner ear malformation

Identification of a Novel Frameshift Variant of POU3F4 and Genetic Counseling of Korean Incomplete Partition Type III Subjects Based on Detailed Genotypes

Characterization of new otic enhancers of the pou3f4 gene reveal distinct signaling pathway regulation and spatio-temporal patterns

Knock-In Mice with Myo3a Y137C Mutation Displayed Progressive Hearing Loss and Hair Cell Degeneration in the Inner Ear

Genetic findings of Sanger and nanopore single-molecule sequencing in patients with X-linked hearing loss and incomplete partition type III

Intraepidermal nerve fibre density at wrist level in diabetic and non‐diabetic patients